Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Shuaiyu Tian"'
Autor:
Binjie Sheng, Kailu Zhang, Shuaiyu Tian, Renyuxue Ma, Zixuan Li, Hai Wu, Tian Wang, Licui Jiang, Fengtao You, Gangli An, Huimin Meng, Lin Yang, Xin Liu
Publikováno v:
Heliyon, Vol 9, Iss 6, Pp e16961- (2023)
CD7 protein as a target is being used to treat CD7+ lymphoma; however, the role of CD7 in the hematopoietic system remains largely unknown. Therefore, we evaluated the effects of CD7 KO in mice. The differentiation of the hematopoietic system in the
Externí odkaz:
https://doaj.org/article/7d249e6d83e2426098ce4f7194c7d5c7
Autor:
Zixuan Li, Zhou Zhou, Shuaiyu Tian, Kailu Zhang, Gangli An, Yarui Zhang, Renyuxue Ma, Binjie Sheng, Tian Wang, Hongying Yang, Lin Yang
Publikováno v:
Cell biology internationalREFERENCES. 46(12)
Reprimo (RPRM), a target gene of p53, is a known tumor suppressor. DNA damage induces RPRM, which triggers p53-dependent G2 arrest by inhibiting cyclin B1/Cdc2 complex activation and promotes DNA damage-induced apoptosis. RPRM negatively regulates at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acaa3ec8118b715c522bdc294062ab1b
https://pubmed.ncbi.nlm.nih.gov/36041213
https://pubmed.ncbi.nlm.nih.gov/36041213
Autor:
Tingting, Zhang, Tian, Wang, Fengtao, You, Zixuan, Li, Dan, Chen, Kailu, Zhang, Shuaiyu, Tian, Binjie, Sheng, Hai, Wu, Licui, Jiang, Renyuxue, Ma, Gangli, An, Huimin, Meng, Lin, Yang
Publikováno v:
Transplant Immunology. 71:101538
Chimeric antigen receptor (CAR) T-cell immunotherapies targeting CD19 can achieve impressive clinical remission rates in the treatment of B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia. However, relapse after CD19-CAR T treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4b84fa84d5c2ca449b7e7956fabd0e0
https://doi.org/10.1016/j.trim.2022.101538
https://doi.org/10.1016/j.trim.2022.101538